Leonteq Securities AG’s Vertex Pharmaceuticals VRTX Stock Holding History

Leonteq Securities AG’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500	Closed	-$233K	–	1345
2024 Q3	$233K	Hold	500	–	–	0.02%	460
2024 Q2	$234K	Buy	+500	New	+$217K	0.02%	448
2022 Q4	–	Sell	-600	Closed	-$174K	–	1366
2022 Q3	$174K	Sell	600 -600	-50%	-$173K	0.01%	548
2022 Q2	$338K	Buy	1,200 +400	+50%	+$107K	0.01%	459
2022 Q1	$209K	Buy	800 +600	+300%	+$142K	0.01%	585
2021 Q4	$43.9K	Sell	200 -1,600	-89%	-$311K	﹤0.01%	930
2021 Q3	$327K	Buy	+1,800	New	+$351K	0.01%	503

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Leonteq Securities AG's VRTX Position: Q2 2026 in Review

Leonteq Securities AG increased its Vertex Pharmaceuticals (VRTX) stake by 4.1% in Q2 2026, buying an estimated $76.7K and bringing the position to 4,433 shares worth $2.2M. The position accounts for 0.08% of the portfolio, ranked #171.

Leonteq Securities AG first reported a position in VRTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.52M in Q3 2021. 597 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Leonteq Securities AG held 4,433 shares of Vertex Pharmaceuticals worth $2.2M as of Q2 2026.
Leonteq Securities AG bought 173 Vertex Pharmaceuticals shares in Q2 2026, an estimated $76.7K.
Vertex Pharmaceuticals made up 0.08% of Leonteq Securities AG's portfolio in Q2 2026, its #171 holding.
Leonteq Securities AG first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
Leonteq Securities AG's Vertex Pharmaceuticals position peaked at $7.52M in Q3 2021.
597 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.